Quest Diagnostics: Catherine Doherty to retire in July 2027, moves to EVP role Nov. 1
Quest Diagnostics said Catherine T. Doherty will retire in July 2027 and will move to an Executive Vice President role effective November 1, 2026, overseeing health systems, its Corewell Health joint venture, and Project Nova. The filing states her base salary is unchanged at $650,000 and her incentive target remains 80% of base salary, with a new $1.2 million restricted stock unit award planned, so the change is a planned succession transition rather than an abrupt departure.
Key points
- Catherine T. Doherty will retire in July 2027 and transition to Executive Vice President effective November 1, 2026.
- Her responsibilities will include health systems, the Corewell Health joint venture, and Project Nova, a multi-year project to modernize Order to Cash business processes.
- The Compensation and Leadership Development Committee approved no change to her $650,000 base salary or 80% incentive target.
- A restricted stock unit award with a target value of $1.2 million has a grant date of November 3, 2026.
The filing
Written by AI on Nov 8, 2026, 1:10 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 06, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.